Navigation Links
Results in Phase I trial of OMP-54F28, a Wnt inhibitor targeting cancer stem cells
Date:5/31/2014

At the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO), University of Colorado Cancer Center researchers reported results of a Phase I trial of OMP-54F28 (FZD8-Fc), an investigational drug candidate discovered by OncoMed Pharmaceuticals targeting cancer stem cells (CSCs). The drug was generally well tolerated, and several of the 26 patients with advanced solid tumors experienced stable disease for greater than six months. Three trials are now open for OMP-54F28 (FZD8-Fc) in combinations with standard therapy for pancreatic, ovarian and liver cancers, being offered at the CU Cancer Center and elsewhere.

"These are optimistic results for one of the first targeted therapies for cancer stem cells," says Antonio Jimeno, MD, PhD, investigator at the CU Cancer Center, director of the university's Cancer Stem Cell-Directed Clinical Trials Program, and principal investigator of the clinical trial at the CU Cancer Center site. "And it is great to work with such a science-focused sponsor, whose vision aligns with ours: bringing to the clinic cutting-edge drugs and ideas that are focused on targeting CSCs. In the context of the collaboration between the Gates Center for Stem Cell Biology and the CU Cancer Center this was the second clinical trial we offered to our patients with the specific intent to eliminate the CSCs in their tumors."

OMP-54F28 (FZD8-Fc) is an antagonist of the Wnt pathway, a key CSC signaling pathway that regulates the fate of these cells. The Wnt pathway is known to be inappropriately activated in many major tumor types, including colon, breast, liver, lung and pancreatic cancers, and is critical for the function of CSCs. Because of this extensive validation, in the Jimeno lab and elsewhere, the Wnt pathway has been a major focus of anti-cancer drug discovery efforts. OMP-54F28 (FZD8-Fc) and a sister compound also developed by OncoMed, vantictumab (OMP-18R5), are two of the first therapeutic agents targeting t
'/>"/>

Contact: Erika Matich
erika.matich@ucdenver.edu
303-524-2780
University of Colorado Denver
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. ChromaDex® Announces Financial Results for the Year Ended 2011
2. Aware, Inc. Reports First Quarter 2012 Financial Results
3. Better housing conditions for zebrafish could improve research results
4. NIH-led study finds genetic test results do not trigger increased use of health services
5. New Tool Helps Drug Developers Optimize Their Research and Target Development for Better Results and a Stronger Competitive Edge
6. Study results: Adult stem cells from bone marrow
7. SF State researcher releases first results from nationwide bee count
8. Aware, Inc. Reports Second Quarter 2012 Financial Results
9. Pilot Results Move GHX Closer to Delivery of Healthcare Industrys First Implantable Device Supply Chain Solution
10. Aware, Inc. Reports Third Quarter 2012 Financial Results
11. Consumers have few negative reactions to the results of genetic testing for cancer mutations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... the wrong food at a restaurant, don,t blame yourself; blame ... do with what you want and more to do with ... and the selections of over 300 diners, the Cornell study ... Management showed that when it comes to what you ... on the menu and how you imagine it will taste. ...
(Date:7/29/2014)... locomotion. Swimming microorganisms, such as bacteria and spermatozoa, are ... viscous forces exerted by the surrounding fluid. Such ... have found that the direction of propulsion made possible ... a viscoelastic fluid. These findings have been published in ... Alternative Energies and Atomic Energy Commission (CEA), in Le ...
(Date:7/29/2014)... Helping people recover from the debilitating effects of ... requires deep knowledge of neurophysiology as well as ... options and outcomes has been the primary focus ... biomedical engineering, since he joined the NJIT faculty ... whose significance is underscored by substantial funding from ...
Breaking Biology News(10 mins):Menu secrets that can make you slim by design 2Optimum inertial self-propulsion design for snowman-like nanorobot 2Continuing the quest for better stroke therapies 2Continuing the quest for better stroke therapies 3
... " Vaccine " published a paper by the Massachusetts based ... important in neurodegenerative Huntington,s disease can be safely used as ... component of every vaccine is an antigen that elicits specific ... Search for better antigens is one of the most ...
... research into heavy metal contaminant levels in dolphins from ... high mercury levels may be a contributing factor to ... Biological Sciences have confirmed levels of mercury found in ... negative health and mental effects and were higher than ...
... Ill. Caloric intake negatively influences sleep patterns in ... be presented on Tuesday at SLEEP 2008, the 22nd ... The study, authored by Ion Zalcman, of Federal ... healthy volunteers between 20-45 years of age. Food ...
Cached Biology News:A protein sequence associated with Huntington’s disease may become life-saving vaccine component 2Mercury contamination found in stranded Victorian dolphins 2Caloric intake negatively influences healthy adults' sleep patterns 2
(Date:7/29/2014)... researchers has created a new way of manufacturing ... surfaces, made by self-assembly of carbon nanotubes, could ... controllable mechanical stiffness and strength, or the ability ... "We have demonstrated that mechanical forces can be ... microstructures, and that we can independently control ...
(Date:7/29/2014)... 2014  Discovery Laboratories, Inc. (Nasdaq: DSCO),  a ... standard of respiratory critical care, will report its second ... before the open of the U.S. financial markets.  ... live teleconference and webcast at 9:00 a.m. Eastern Time ... Labs, management will discuss the 2014 second quarter ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 TransVac Solutions, ... linen collection and transport solutions for hospitals, will be ... Healthcare Engineering (ASHE) Annual Conference & Technical Exhibition Aug. ... present its technology for making hospitals cleaner, reducing infection ... over the hospital’s life cycle. Staff will be ...
(Date:7/29/2014)... DisasterTalk is a texting app which allows users ... or other transmitters are down. The app can transmit messages ... need for any Wi-Fi, and can also use a meshworth ... has launched as a housing report finds that ... of being affected by natural disasters. With the risk hitting ...
Breaking Biology Technology:A new way to make microstructured surfaces 2Discovery Labs to Report 2014 Second Quarter Financial Results and Hold Conference Call on Tuesday, August 5, 2014 at 9:00 a.m. Eastern Time 2TransVac Presents Cost Saving Technology at ASHE Conference for Keeping Hospitals Cleaner 2DisasterTalk App Could Save Lives as Report Reveals 8% of US Homes at Very High Risk of Natural Disaster 2
... organizations talk a good game about interpersonal skills, influence and ... a pretty clear chain of command that runs right down ... (DoIT) at the University of Wisconsin-Madison, Annie Stunden ... many more staff with IT responsibilities in other departments on ...
... this year intend to provide more mentorship to the ... during the inaugural competition in 2004. , ,Now that the ... a panel of dozens of judges will narrow the 200 ... for a further round of elimination. Sometime in March they ...
... the important impact that generic pharmaceutical drugs are having ... and growth spurs Big Pharma to invest heavily in ... having any kind of medical health insurance in the ... Canada being rapidly shut by U.S. pharmaceutical companies, the ...
Cached Biology Technology:Annie Stunden, CIO at the University of Wisconsin-Madison 2Annie Stunden, CIO at the University of Wisconsin-Madison 3Annie Stunden, CIO at the University of Wisconsin-Madison 4Coaching available for business-plan contest survivors 2Pharmas will be forced into generic-drug strategy 2Pharmas will be forced into generic-drug strategy 3
Anti 4-hydroxy-2-hexenal (4-HHE) Monoclonal Antibody (HNEJ-2)...
... EnVision™ G|2 Doublestain System is ... generation visualization kit. The kit is ... the simultaneous detection of two different ... is compatible with suitably diluted rabbit ...
... this enzyme exists predominantly as XDH which ... a critical plasma antioxidant. During ischemia, ... radical producing XO by oxidation of essential ... cleavage of the amino-terminus. AO has ...
Mouse monoclonal antibody to Lats2....
Biology Products: